The Butenediol segmentation by application delineates four primary demand drivers: pharmaceuticals, agrochemicals, polymers, and personal‑care products. In the pharmaceutical segment, 1,3‑butanediol serves as a chiral building block for active‑pharmaceutical‑ingredients (APIs), accounting for roughly 35 % of total market revenue due to high‑value synthesis pathways and regulatory premium pricing. Agrochemical usage, representing about 25 % of the market, leverages both 1,3‑ and 2,3‑butanediol as intermediates for herbicide and pesticide precursors, where volume growth is tied to expanding global crop‑protection budgets. The polymer segment, also at 25 %, incorporates butenediol into polyesters and polyurethanes, driving demand through automotive and construction applications that require lightweight, high‑performance materials. Finally, personal‑care consumes approximately 15 % of the market, utilizing the solvent and humectant properties of butenediol in cosmetics and skin‑care formulations. Collectively, these application sub‑segments shape the overall market size by balancing high‑margin specialty uses against high‑volume commodity consumption.